Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Resectable NSCLC”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946836
What this trial is testing

Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical Study

Who this might be right for
Resectable Non-small Cell Lung CancerBispecific AntibodyNeoadjuvant Therapy
Shanghai Pulmonary Hospital, Shanghai, China 80
Early research (Phase 1)Study completedNCT03732664
What this trial is testing

ICIs Neoadjuvant Therapy in Resectable Non-Small-Cell Lung Cancer

Who this might be right for
High-Risk Resectable NSCLC
Second Affiliated Hospital, Zhejiang University, School of Medicine 27
Testing effectiveness (Phase 2)UnknownNCT04922138
What this trial is testing

Aumolertinib Adjuvant Therapy of Resectable Stage I EGFRm+ NSCLC With High-grade Patterns

Who this might be right for
Lung Cancer
Baohui Han 104
Testing effectiveness (Phase 2)Looking for participantsNCT07534033
What this trial is testing

Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer

Who this might be right for
NSCLC Diagnosed by Histology or CytologyA Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical ResectionOverall Lung Function is Adequate for the Planned Lung Resection+1 more
Zhujiang Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07450183
What this trial is testing

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

Who this might be right for
Lung Cancer (NSCLC)
Henry Ford Health System 33
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Very early researchEnded earlyNCT03870529
What this trial is testing

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerStage I Lung CancerStage Ib Lung Carcinoma+3 more
Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07182708
What this trial is testing

High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)EGFR Activating MutationResectable Lung Non-Small Cell Carcinoma
Peking University Cancer Hospital & Institute 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07746388
What this trial is testing

Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial

Who this might be right for
NsclcNSCLC Stage IINSCLC, Stage III+2 more
University of Maryland, Baltimore 30
Testing effectiveness (Phase 2)Looking for participantsNCT06924398
What this trial is testing

Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）

Who this might be right for
Lung Cancer (NSCLC)
Sun Yat-sen University 32
46